Work

Phase I/II Trial of the Efficacy and Safety of Combination Therapy with Lenalidomide/Bortezomib/Dexamethasone (RVD) and Panobinostat in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.187.187

Authors: Jatin J. Shah, Lei Feng, Elisabet E. Manasanch, Donna Weber, Sheeba K Thomas, Francesco Turturro, Nina Shah, Uday R. Popat, Yago Nieto, Qaiser Bashir, Silvia C Munoz, Ashley Landry, Kathleen Mendoza, Richard E. Champlin, Muzaffar H. Qazilbash, Robert Z. Orlowski

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980107656

FWCI: 2.611

Cites:

Cited by: 12

Related to: 10